Mechanism underlying the block of human Cav3.2 T-type Ca 2+ channels by benidipine, a dihydropyridine Ca2+ channel blocker

Life Sciences

Volumn 88, Issue 19-20, 2011, Pages 898-907

  Inayoshi, Atsushi ^a   Sugimoto, Yoshiyuki ^a   Funahashi, Jun ^a   Takahashi, Saori ^a   Matsubara, Masahiro ^a   Kusaka, Hideaki ^a  

^a KYOWA HAKKO KOGYO CO LTD   (Japan)

Author keywords

Benidipine; Cav3.2; Ca2+ channel blocker; Ca2+ mobilization; HEK 293 cells; T type Ca2+ channel; Whole cell patch clamp

Indexed keywords

AMLODIPINE; BENIDIPINE; CALCIUM CHANNEL T TYPE; EFONIDIPINE; NIFEDIPINE;

ARTICLE; CALCIUM CURRENT; CALCIUM TRANSPORT; CHANNEL GATING; DRUG MECHANISM; ENANTIOMER; HUMAN; HUMAN CELL; IC 50;

CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, T-TYPE; DIHYDROPYRIDINES; HEK293 CELLS; HUMANS; ION CHANNEL GATING;

EID: 79955522056     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2011.03.019     Document Type: Article

References (29)

1. 2+ channels by benidipine, a dihydropyridine calcium channel blocker, inhibits aldosterone production in human adrenocortical cell line NCI-H295R Eur J Pharmacol 584 2-3 2008 424 434
2. J.E. Arrowsmith, S.F. Campbell, P.E. Cross, J.K. Stubbs, R.A. Burges, and D.G. Gardiner Long-acting dihydropyridine calcium antagonists. 1. 2-Alkoxymethyl derivatives incorporating basic substituents J Med Chem 29 9 1986 1696 1702 (Pubitemid 16018197)
3. 2+ channels Annu Rev Cell Dev Biol 16 2000 521 555 (Pubitemid 32037516)
4. W.A. Catterall, E. Perez-Reyes, T.P. Snutch, and J. Striessnig International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels Pharmacol Rev 57 4 2005 411 425 (Pubitemid 43036432)
5. J. Chemin, A. Monteil, C. Briquaire, S. Richard, E. Perez-Reyes, and J. Nargeot Overexpression of T-type calcium channels in HEK-293 cells increases intracellular calcium without affecting cellular proliferation FEBS Lett 478 1-2 2000 166 172 (Pubitemid 30462279)
6. 2+ channel Mol Pharmacol 70 2 2006 718 726 (Pubitemid 44092332)
7. 2+ channels Br J Pharmacol 143 8 2004 1050 1057 (Pubitemid 40065506)
8. 2+ channel (α1G) expressed in Xenopus oocytes J Cardiovasc Pharmacol 45 3 2005 241 246 (Pubitemid 40328146)
9. 1I)) expressed in Xenopus oocytes Eur J Pharmacol 613 1-3 2009 100 107
10. 2+ channels in cortisol-secreting cells J Pharmacol Exp Ther 292 1 2000 96 103 (Pubitemid 30026358)
11. 2+ channel subtypes and pharmacology in the kidney Circ Res 100 3 2007 342 353
12. A. Ishii, K. Nishida, T. Oka, and N. Nakamizo Receptor binding properties of the new calcium antagonist benidipine hydrochloride Arzneimittelforschung 38 11A 1988 1677 1680
13. T. Kawata, S. Hashimoto, and T. Koike Diversity in the renal hemodynamic effects of dihydropyridine calcium blockers in spontaneously hypertensive rats J Cardiovasc Pharmacol 30 4 1997 431 436 (Pubitemid 27527577)
14. P.P. Kumar, S.C. Stotz, R. Paramashivappa, A.M. Beedle, G.W. Zamponi, and A.S. Rao Synthesis and evaluation of a new class of nifedipine analogs with T-type calcium channel blocking activity Mol Pharmacol 61 3 2002 649 658 (Pubitemid 34171931)
15. R.L. Martin, J.H. Lee, L.L. Cribbs, E. Perez-Reyes, and D.A. Hanck Mibefradil block of cloned T-type calcium channels J Pharmacol Exp Ther 295 1 2000 302 308
16. 2+ current by efonidipine in cardiomyocytes Life Sci 68 3 2000 345 351
17. T. Morikawa, M. Okumura, Y. Konishi, N. Okada, and M. Imanishi Effects of benidipine on glomerular hemodynamics and proteinuria in patients with nondiabetic nephropathy Hypertens Res 25 4 2002 571 576
18. K. Muto, T. Kuroda, H. Kawato, A. Karasawa, K. Kubo, and N. Nakamizo Synthesis and pharmacological activity of stereoisomers of 1,4-dihydro-2,6- dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid methyl 1-(phenylmethyl)-3-piperidinyl ester Arzneimittelforschung 38 11A 1988 1662 1665
19. 2+ channels in cardiac pacemaking J Pharmacol Sci 99 3 2005 197 204 (Pubitemid 41686441)
20. E. Perez-Reyes Molecular physiology of low-voltage-activated T-type calcium channels Physiol Rev 83 1 2003 117 161 (Pubitemid 36459879)
21. 2+ channels: block by antihypertensives, antiarrhythmics, and their analogs J Pharmacol Exp Ther 328 2 2009 621 627
22. 2+ channels Biochem Pharmacol 69 5 2005 841 854 (Pubitemid 40248626)
23. 2+ channels as therapeutic targets in the nervous system Curr Opin Pharmacol 8 1 2008 33 41
24. 2+ channels Eur J Pharmacol 375 1-3 1999 311 325 (Pubitemid 29317613)
25. T. Uzu, M. Nishimura, T. Fujii, M. Sakaguchi, M. Kanasaki, and K. Isshiki Benidipine attenuates glomerular hypertension and reduces albuminuria in patients with metabolic syndrome Hypertens Res 30 2 2007 161 165 (Pubitemid 46541790)
26. 2+ channels in the heart Cell Calcium 40 2 2006 205 220 (Pubitemid 43942302)
27. v3.2 (T-type) channels Assay Drug Dev Technol 1 5 2003 637 645
28. v3 T-type channels using molecular and pharmacologic approaches Assay Drug Dev Technol 5 2 2007 191 203 (Pubitemid 46684907)
29. K. Yao, K. Nagashima, and H. Miki Pharmacological, pharmacokinetic, and clinical properties of benidipine hydrochloride, a novel, long-acting calcium channel blocker J Pharmacol Sci 100 4 2006 243 261